Father, husband, physician, scientist
Oslo, Norge
Joined January 2012
- Tweets439
- Following212
- Followers360
- Likes1.1K
Johannes E. R. Hov retweeted
RESEARCH | @antoniomol83 @BackhedLab @hov_jer , P Braadland et al. (Oslo University Hospital, University of Gothenburg)
The gut microbial metabolite imidazole propionate is shown to promote primary sclerosing cholangitis.
nature.com/articles/s42255-0…
Johannes E. R. Hov retweeted
New @TheLancet - Faecal microbiota transplantation in irritable bowel syndrome (REFIT2): a randomised, double-blind, placebo-controlled, phase 3 trial
thelancet.com/journals/lance…
#FMT #GITwitter #MedTwitter #IBS
Years of work from so many people - I believe this is an important step forward in PSC! @antoniomol83 @BackhedLab @ERC_Research @tomhemmingk @Melum_E
Gut microbiota-derived imidazole propionate promotes primary sclerosing cholangitis via p38 signalling dlvr.it/TVKKRx
Johannes E. R. Hov retweeted
How can we better predict disease progression in PSC?
New research highlights active vitamin B6 as a potential prognostic biomarker. Studies suggest measuring B6 could help assess risk & improve monitoring for people living with #PSC.
➡️ buff.ly/dqOmSUj #LetsBeatPSC
Johannes E. R. Hov retweeted
Original Article
Multimodal transcriptomics identifies metallothionein as a novel pathway in primary sclerosing cholangitis
Chung et al.
#LiverX
tinyurl.com/urkyxsms
Johannes E. R. Hov retweeted
@TheLancet @EASLnews second Liver Commission report is online. What a tremendous team effort. A roadmap for health, far beyond that pertaining to liver disease. thelancet.com/journals/lance…
Johannes E. R. Hov retweeted
PSC is rare, progressive, and still without an effective medical therapy. Our UEG online course, led by Johannes Hov & Trine Folseraas, covers the essentials of PSC – from bile duct inflammation & fibrosis to its links with IBD & cancer risk.
🔗 bit.ly/4tI6KEs
Johannes E. R. Hov retweeted
From genetic associations to environmental triggers in PSC. Our EBV-paper is out in @NatureMedicine today. nature.com/articles/s41591-0…
Johannes E. R. Hov retweeted
Very happy to announce that our PSC study is now online at Nature Medicine (nature.com/articles/s41591-0…). Great work team! @miGutHealth @DFG_miTarget @BioInfoGen1
Interested in microbiota, mouse models, liver disease and working on an ERC Consolidator grant-funded project? Apply for a postdoc position in my lab! jobbnorge.no/en/available-jo…
Fantastic to get a new ERC grant! Why is IBD associated with both PSC and steatosis? In the #ERCCoG project #FatVersusBile we will use IBD as a window to the microbial signals from the gut that shape liver health. Exciting days! @ERC_Research @RIIM_UiO_OUS @UniOslo_MED @erc_ncp
Johannes E. R. Hov retweeted
🧐 Did you know that smoking & coffee may actually lower the risk of developing Primary Sclerosing Cholangitis (PSC)? While genetics play a role, environmental factors have an even greater impact on this disease. 📢 Learn more & enrol in the #UEGEdu course bit.ly/4cPMpnG
ALT eine Hand mit einer Zigarette und einer Tasse Kaffee
Happy to be in Stockholm for the #ipscsg biennial meeting - and listen to a great talk from @KatrineTer about her work on biomarkers in recurrent PSC @Melum_E
Johannes E. R. Hov retweeted
Discover the essentials of #PrimarySclerosingCholangitis in our new online course by Johannes Hov and Trine Folseraas! Learn about this chronic liver disease, its link to inflammatory bowel disease, & its management.
Enrol now 🔗 bit.ly/4cPMpnG
#UEGEdu #myUEGcommunity
#nopsc gathering in Milano for @EASLnews 2024 celebrating @tomhemmingk and great scientific efforts from everyone @Melum_E
Johannes E. R. Hov retweeted
Congratulations! Very well deserved!
Dr Tom Hemming Karlsen has been honored with the EASL Recognition Award at #EASLCongress for his contributions and dedication to the field of hepatology.
Dr. Karlsen graduated from the University of Bergen, Norway, in 1997. His journey in medicine has seen him appointed as Professor of Gastroenterology at the University of Bergen in 2012, and later, as Professor of Internal Medicine at the University of Oslo in 2014.
Currently, he serves as the Head of Research of the Division of Surgery, Inflammatory Medicine, and Transplantation at Oslo University Hospital. He is also the leader of the Norwegian PSC research center, where his work continues to make significant strides in understanding and treating liver diseases.
This year's award is a recognition of Dr. Karlsen's immense integrity, honesty, and genuine love for others. His contributions extend beyond research; his generosity and commitment have profoundly impacted the hepatology community.
"All of us here today are behind this achievement, and I would like to also congratulate all of my collaborators" - Tom Hemming Karlsen
Johannes E. R. Hov retweeted
How does the future look for immune mediated liver diseases? Packed room for a fantastic panel! @EASLnews @AlessioGerussi @ERN_RARE_LIVER @josewillemse @hov_jer @macarlotal
🙏🏻 to the chairs: Bettina Hansen, Ynte de Boer, and Christoph Schramm
Johannes E. R. Hov retweeted
Annual research retreat of the Norwegian PSC research center. Such a great team on a dedicated mission to resolve a remaining mystery of hepatology. @PSCPartners
Johannes E. R. Hov retweeted
Great start in this year! Big congrats to @Weifeng_Lin13 for his publication in @angew_chem detailing our newly developed chemoselective probe for bifunctional mass spec investigation of carboxylic acid- & carbonyl-containing metabolites in human samples.
onlinelibrary.wiley.com/doi/…
Johannes E. R. Hov retweeted
This summer Professor Hanns-Ulrich Marshall passed away and we lost an amazing friend and coworker. He will always be remembered for his humor, big heart and sharp mind❤️ journal-of-hepatology.eu/art…
